Ballantyne CM - Search Results

1

Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD.

Belalcazar LM, Lang W, Haffner SM, Schwenke DC, Kriska A, Balasubramanyam A, Hoogeveen RC, Pi-Sunyer FX, Tracy RP, Ballantyne CM; Look AHEAD (Action for Health in Diabetes) Research Group. Belalcazar LM, et al. Among authors: ballantyne cm. Diabetes Care. 2015 Aug;38(8):1544-50. doi: 10.2337/dc14-2775. Epub 2015 May 13. Diabetes Care. 2015. PMID: 25972574 Free PMC article. Clinical Trial.

2

Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterol.

Belalcazar LM, Ballantyne CM. Belalcazar LM, et al. Among authors: ballantyne cm. Prog Cardiovasc Dis. 1998 Sep-Oct;41(2):151-74. doi: 10.1016/s0033-0620(98)80010-8. Prog Cardiovasc Dis. 1998. PMID: 9790415 Review.

3

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Morrisett JD, Abdel-Fattah G, Hoogeveen R, Mitchell E, Ballantyne CM, Pownall HJ, Opekun AR, Jaffe JS, Oppermann S, Kahan BD. Morrisett JD, et al. Among authors: ballantyne cm. J Lipid Res. 2002 Aug;43(8):1170-80. J Lipid Res. 2002. PMID: 12177161 Free article.

4

Impact of weight loss on the metabolic syndrome.

Case CC, Jones PH, Nelson K, O'Brian Smith E, Ballantyne CM. Case CC, et al. Among authors: ballantyne cm. Diabetes Obes Metab. 2002 Nov;4(6):407-14. doi: 10.1046/j.1463-1326.2002.00236.x. Diabetes Obes Metab. 2002. PMID: 12406040

5

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study. Duncan BB, et al. Among authors: ballantyne cm. Diabetes. 2003 Jul;52(7):1799-805. doi: 10.2337/diabetes.52.7.1799. Diabetes. 2003. PMID: 12829649

6

Long-term, randomized clinical trial of two diets in the metabolic syndrome and type 2 diabetes.

Scott LW, Balasubramanyam A, Kimball KT, Aherns AK, Fordis CM Jr, Ballantyne CM. Scott LW, et al. Among authors: ballantyne cm. Diabetes Care. 2003 Aug;26(8):2481-2. doi: 10.2337/diacare.26.8.2481. Diabetes Care. 2003. PMID: 12882894 Clinical Trial. No abstract available.

7

Leptin and incident type 2 diabetes: risk or protection?

Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G; ARIC Investigators. Schmidt MI, et al. Among authors: ballantyne cm. Diabetologia. 2006 Sep;49(9):2086-96. doi: 10.1007/s00125-006-0351-z. Epub 2006 Jul 19. Diabetologia. 2006. PMID: 16850292

8

Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

Hoogeveen RC, Ballantyne CM, Bang H, Heiss G, Duncan BB, Folsom AR, Pankow JS. Hoogeveen RC, et al. Among authors: ballantyne cm. Diabetologia. 2007 Jan;50(1):36-42. doi: 10.1007/s00125-006-0533-8. Epub 2006 Nov 29. Diabetologia. 2007. PMID: 17136392

9

Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study.

Ballantyne CM, Hoogeveen RC, McNeill AM, Heiss G, Schmidt MI, Duncan BB, Pankow JS. Ballantyne CM, et al. Int J Obes (Lond). 2008 May;32 Suppl 2(Suppl 2):S21-4. doi: 10.1038/ijo.2008.31. Int J Obes (Lond). 2008. PMID: 18469836 Free PMC article.

10

Statin-induced diabetes: will it change clinical practice?

Belalcazar LM, Raghavan VA, Ballantyne CM. Belalcazar LM, et al. Among authors: ballantyne cm. Diabetes Care. 2009 Oct;32(10):1941-3. doi: 10.2337/dc09-1277. Diabetes Care. 2009. PMID: 19794006 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,019 results

Search Page